Current Emergency Medical Service Vasoactive Use for the Management of Shock
International EMS vasoactive use in the management of shock is heterogeneous. Future randomized controlled trials should aim to elucidate optimal prehospital treatment strategies for shock, including the initiation, choice of agent, and monitoring of vasoactive medication.
Authors
- David M. Kaye (ORCID: https://orcid.org/0000-0003-4058-0372)
- Ziad Nehme (ORCID: https://orcid.org/0000-0003-2432-1645)
- Jocasta Ball (ORCID: https://orcid.org/0000-0002-1512-4255)
- Amminadab L Eliakundu
- Derek P. Chew (ORCID: https://orcid.org/0000-0003-3593-296X)
- Jason Bloom (ORCID: https://orcid.org/0000-0001-8838-0332)
- Dion Stub (ORCID: https://orcid.org/0000-0001-8686-2709)
- Vishal Goel (ORCID: https://orcid.org/0000-0002-6786-4941)
- Susie Cartledge (ORCID: https://orcid.org/0000-0002-6837-2244)
- David Anderson
- William Chan
Institutions
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- The Alfred Hospital (AU)
- Ambulance Victoria (AU)
- Western Health (AU)
- Australian Centre for Heart Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Critical Care Explorations
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1097/cce.0000000000001177
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Abiomed
- National Heart Foundation of Australia
- Monash University
- Medical Research Council
- National Health and Medical Research Council